Literature DB >> 8630313

Impaired implantation after in vitro fertilisation treatment associated with hydrosalpinx.

C Fleming1, M G Hull.   

Abstract

OBJECTIVE: To study whether the presence of hydrosalpinx affected success after in vitro fertilisation (IVF) in women with inflammatory tubal damage.
DESIGN: Retrospective, nonrandomised study.
SETTING: University private IVF clinic with complete fertility services. PARTICIPANTS: Two study groups (79 women with hydrosalpinges and 198 women with inflammatory tubal damage but no hydrosalpinx) and a third group (22 sterilised, previously fertile women) for comparison. MAIN OUTCOME MEASURES: Clinical pregnancy and livebirth rates per embryo transfer cycle; implantation and live baby rates per individual embryo transferred.
RESULTS: The hydrosalpinx group had a significantly lower implantation rate per embryo (8.2%) and chance of a live baby per embryo transferred (5.6%), compared with the nonhydrosalpinx group (14.9% and 11.2%, respectively). The hydrosalpinx group also had a lower clinical pregnancy rate (23%) and live birth rate per transfer cycle (17%) compared with the nonhydrosalpinx group (30% and 26%), but these differences were not significant.
CONCLUSIONS: The presence of a hydrosalpinx halves the chance of an embryo implanting, probably due to physical or toxic chemical effects of fluid draining from the hydrosalpinx into the uterine cavity. Women with hydrosalpinges may benefit from distal salpingostomy or salpingectomy as a drainage procedure before in vitro fertilisation treatment, even though such surgery may not increase the chances of natural conception.

Entities:  

Mesh:

Year:  1996        PMID: 8630313     DOI: 10.1111/j.1471-0528.1996.tb09717.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  12 in total

1.  Controlled ovarian hyperstimulation adversely affects implantation following in vitro fertilization-embryo transfer.

Authors:  J H Check; J K Choe; D Katsoff; D Summers-Chase; C Wilson
Journal:  J Assist Reprod Genet       Date:  1999-09       Impact factor: 3.412

2.  How members of the Society for Reproductive Endocrinology and Infertility and Society of Reproductive Surgeons evaluate, define, and manage hydrosalpinges.

Authors:  Kenan Omurtag; Natalia M Grindler; Kimberly A Roehl; Gordon Wright Bates; Angeline N Beltsos; Randall R Odem; Emily S Jungheim
Journal:  Fertil Steril       Date:  2012-03-09       Impact factor: 7.329

3.  Salpingectomy for repeated embryo nonimplantation after in vitro fertilization in patients with severe tubal factor infertility.

Authors:  H Dechaud; T Anahory; N Aligier; F Arnal; H Humeau; B Hedon
Journal:  J Assist Reprod Genet       Date:  2000-04       Impact factor: 3.412

4.  The presence of hydrosalpinx may not adversely affect the implantation and pregnancy rates in in vitro fertilization treatment.

Authors:  E H Ng; W S Yeung; P C Ho
Journal:  J Assist Reprod Genet       Date:  1997-10       Impact factor: 3.412

5.  An increased number of replaced embryos counteracts the adverse effect of hydrosalpinges on IVF/ET outcome.

Authors:  K H Abd-el-Maeboud; E al-Dein M Khalifa; E S el-Hussein
Journal:  J Assist Reprod Genet       Date:  1998-01       Impact factor: 3.412

6.  Effect of endometrial cavity fluid on clinical pregnancy rate in tubal embryo transfer (TET).

Authors:  Robert Kuo-Kuang Lee; San-Li Yu; Yu-Fen Chih; Yi-Chun Tsai; Ming-Huei Lin; Yuh-Ming Hwu; Wen-Yu Huang; Jin-Tsung Su
Journal:  J Assist Reprod Genet       Date:  2006-05       Impact factor: 3.412

7.  Effects of hydrosalpingeal fluid on murine embryo development and implantation.

Authors:  J E Roberts; H J Clarke; T Tulandi; S L Tan
Journal:  J Assist Reprod Genet       Date:  1999-09       Impact factor: 3.412

8.  The presence of cytokines and growth factors in hydrosalpingeal fluid.

Authors:  Annika Strandell; Jane Thorburn; Ann Wallin
Journal:  J Assist Reprod Genet       Date:  2004-07       Impact factor: 3.412

9.  State-mandated insurance coverage is associated with the approach to hydrosalpinges before IVF.

Authors:  Kenan Omurtag; Natalia M Grindler; Kimberly A Roehl; G Wright Bates; Angeline N Beltsos; Randall R Odem; Emily S Jungheim
Journal:  Reprod Biomed Online       Date:  2014-03-24       Impact factor: 3.828

Review 10.  Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.

Authors:  Neil Johnson; Sabine van Voorst; Martin C Sowter; Annika Strandell; Ben Willem J Mol
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.